Evolution Infographics
Cell & Gene Therapy: Increasing Demand for Viral Vectors Drives Biomanufacturing Innovation & CDMO Investment
Cell & Gene Therapy: Increasing Demand for Viral Vectors Drives Biomanufacturing Innovation & CDMO Investment
More
Share
The Future of Biomanufacturing: Automated Closed Systems for Cell & Gene Therapy Processes
The Future of Biomanufacturing: Automated Closed Systems for Cell & Gene Therapy Processes
More
Share
The Future of Biomanufacturing: In Silico Modelling
The Future of Biomanufacturing: In Silico Modelling
More
Share
Evolution Infographics
Lonza Opens the World’s Largest Cell & Gene Therapy Manufacturing Plant in Texas
Lonza Opens the World’s Largest Cell & Gene Therapy Manufacturing Plant in Texas
More
Share
Evolution Infographics
Manufacturing Gene Therapies: An Impending Crisis or Temporary Growing Pains?
Manufacturing Gene Therapies: An Impending Crisis or Temporary Growing Pains?
More
Share
The Future of BioManufacturing: Cell Line Engineering
The Future of BioManufacturing: Cell Line Engineering
More
Share
The Future of BioManufacturing: Modular Factories & End-to-End Solutions
More
Share
Evolution Infographics
Thermo Fisher Strengthens Vertical Integration with $7.2B Acquisition of CDMO Patheon
Thermo Fisher Strengthens Vertical Integration with $7.2B Acquisition of CDMO Patheon
More
Share
The Future of BioManufacturing: Disposable Single-Use Technologies
More
Share
Evolution Infographics
Lonza’s $5.5B Acquisition of Capsugel Accelerates its “Healthcare Continuum” Strategy
Lonza’s $5.5B Acquisition of Capsugel Accelerates its “Healthcare Continuum” Strategy
More
Share
News & Analysis
Lonza Half-Year Business Performance Fully on Track

Lonza Half-Year Business Performance Fully on Track Business is fully on track with a CORE EBIT growth of 13.1% compared with the first half of 2013 despite currency headwinds Revenue

More
Share